MYCOTEX is a biomaterial technology company founded by Aniela Hoitink and driven by a multidisciplinary team of biochemists, robotics and application specialists, alongside experienced commercial and operational professionals, based in Amersfoort, the Netherlands.
As a pioneer in mycelium-based material technology, MYCOTEX has developed one of the most advanced platforms for creating high-performance biomaterials. By combining next-generation mycelium based biodegradable and regenerative materials for existing supply chains and proprietary 3D manufacturing processes, our platform enables designers, companies, and brands to develop and scale cutting-edge bio-based products while significantly reducing environmental impact.
-
Bio-material Laboratory and Testing
Our fully equipped laboratory and material testing facility is where our bio, polymer and colour chemists pioneer the latest mycelium-based technologies. Here, they explore new ideas, develop advanced materials, and push the boundaries of what is possible, by challenging conventional solutions to create the next generation of sustainable innovation
-
3D Design and Printing
Our fully equipped 3D modelling and printing room, enables our designers and engineers to rapidly develop and refine advanced designs and moulds. This integrated capability allows us to support our clients’ needs across both R&D and commercial scaling, translating bio-material concepts into precise, production-ready solutions with speed and accuracy.
-
Pilot Application Lab
In our pilot application lab, we operate a dedicated development playground where our engineers transform biomaterials into real-world applications and products. Through advanced moulding, forming, and spraying techniques, the team continuously experiments and refines processes, identifying the most effective and scalable manufacturing methods for each material developed.
Industry Recognised Awards
MYCOTEX is recognized by the industry with multiple grants and awards for delivering integrated material R&D and end-to-end supply chain solutions.
INVESTORS
